WELCURE DRUGS & PHARMACEUTICALS LTD. SHARE PRICE [LIVE]

  
NSE: WELCURE
N/A
BSE: 524661
3.96
To view real time prices Login to your account
OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
BSE Click here to view BSE data
Live Chart
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality

Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Not Applicable
Sector
-10.76%
Sensex
0.72%
IndustryPharma
MARKET CAP (Micro Cap Stock)Rs Cr
PE (TTM) 0.00
DIVIDEND YIELD 0.00%
PE Ratio5.35
Price to Book Value3.96
EV to EBIT-3.89
EV to EBITDA-3.89
EV to Capital Employed-3.89
EV to Sales3.89
PEG Ratio0.00
Dividend YieldNA
ROCE (Latest)Negative Capital Employed
ROE (Latest)2.96%
NameDec 22Sep 22
Promoters (Change:0.00) 0%0%
FIIs (Change:0.00) 0%0%
Mutual Funds (Change:0.00) 0%0%
Insurance Companies (Change:0.00) 0%0%
Other DIIs (Change:0.00) 0.01%0.01%
Non Institution (Change:0.00) 99.99%99.99%

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in WELCURE DRUGS & PHARMACEUTICALS LTD.

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

WELCURE News

Frequently Asked Questions

What is the Share price of WELCURE DRUGS & PHARMACEUTICALS LTD. (WELCURE)?

WELCURE DRUGS & PHARMACEUTICALS LTD. (WELCURE) share price as of April 1, 2023, on BSE is Rs 3.96 (BSE).

Can I buy WELCURE DRUGS & PHARMACEUTICALS LTD. (WELCURE) shares?

Yes, You can buy WELCURE DRUGS & PHARMACEUTICALS LTD. (WELCURE) shares by opening a Demat account with Angel One.

How do I buy WELCURE DRUGS & PHARMACEUTICALS LTD. (WELCURE) from Angel One?

WELCURE DRUGS & PHARMACEUTICALS LTD. (WELCURE) share can be brought through the following modes:
  1. Direct investment: You can buy WELCURE DRUGS & PHARMACEUTICALS LTD. (WELCURE) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to WELCURE DRUGS & PHARMACEUTICALS LTD. (WELCURE) shares.

In which sector do WELCURE DRUGS & PHARMACEUTICALS LTD. (WELCURE) belong?

WELCURE DRUGS & PHARMACEUTICALS LTD. (WELCURE) belongs to Pharma.

About WELCURE

Today's live share price for WELCURE DRUGS & PHARMACEUTICALS LTD. is NSE: N/A, BSE: ₹ 3.96 with a current market capitalization of .

Incorporated on 4 Jun.'92, Welcure Drugs And Pharmaceuticals (WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain. The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. The company is managed by managing director D C Jain. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 7-cr project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL). The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations. It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen. It manufactures over a hundred varieties of tablets, capsules and dry syrups, sulpha drugs, vitamins, analgesics, etc. Its subsidiary, AKL, manufactures 6-APA, a key drug intermediate in the manufacture of semi-synthetic penicillin. The company has decided to set up new sections of paediatrics and veterinary drugs and to diversify into ointments and liquid syrups. The new products of the company WELSTAP , X- CLOX , ETHAMBUTOL, RIFA- Z , CETIRIZIN , NORTIN have been well accepted in the market. The Company has entered into a collaboration agreement with a russian company to act as their sole selling agent for a unique medicine Stevioside, an alternate to sugar, Saccharin and Aspartame. The Company has added a new liquid oral plant in Bhiwadi, Rajasthan. It has obtained ISO 9002 certification with double accredition from ABS Quality Evaluation Inc Texas and by Registrar of Accredition Board of USA. Welcure has also entered into an agreement with Bihar Drugs and Chemicals Ltd, a government of Bihar undertaking, for manufacturing their products in its factory on loan basis. During the year 2000-01 the company had launched some products like CEZEN,DIMCIN PLUS,OXIN,SPASWIN etc.The company has entered into technical collaboration agreement with Advanced Medical Care Inc New Jersey USA for setting up of joint venture facilities in the existing plant of the company. During the year 2001-02, the company had launched products like B-ZEX, DMART PLUS, DRALPIN, DUKESPAS, DUBAMOL, HISTACURE, KUFFWEL, KINGSPAS, LANAX, PETRIMAX, PEEROSCAM, RENACT, SARVO, WELCEE, WELGESIC, WELIC, WELOXY, WELRELEEF, X-DRYL. The company has changed its marketing policy from "Sales through Wholesale Distributors" to " Sales at Doorstep" by reaching every corner of the country and by putting dual force on Sales-through sales personnel on one hand and through stockists and distributors on the other hand.

Read more

Enjoy Zero Brokerage on Equity Delivery

Join our 1 Cr+ happy customers